Icon

ORBACTIV (nda206334)- (EQ 400MG BASE/VIAL)

ORITAVANCIN DIPHOSPHATE MELINTA THERAP
EQ 400MG BASE/VIAL
No No
2035-Jul-16 2019-Aug-06
None None
2024-Aug-06 No
ORBACTIV is a lipoglycopeptide antibacterial drug indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 400MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.